| Financial Year |
March 31 2023 |
| Monetary Funds |
279,659,444.85 |
| Held-for-trading Financial Assets |
301,713,656.26 |
| Notes Receivable |
-- |
| Accounts Receivable |
357,799,935.11 |
| Advances to Suppliers |
61,051,241.29 |
| Other Receivables |
17,816,619.20 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
2,838,803.96 |
| Dividend Receivable |
-- |
| Inventories |
365,523,461.04 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
175,913,123.60 |
| Total Current Assets |
1,565,351,020.13 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
45,195,195.60 |
| Investment Properties |
-- |
| Fixed Assetes |
102,998,544.41 |
| Under-construction Projects |
14,471,470.37 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
3,929,992.27 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
1,465,612.73 |
| Deferred Income Tax Assets |
37,634,206.14 |
| Other Non-Current Assets |
200,863,004.84 |
| Sub-Total of Non-Current Assets |
442,456,815.65 |
| Total Assets |
2,007,807,835.78 |
| Short-Term Loans |
201,897,424.93 |
| Trading Financial liabilities |
-- |
| Notes Payable |
3,726,945.75 |
| Accounts Payable |
109,687,055.36 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
42,345,715.63 |
| Taxes Payable |
34,998,296.51 |
| Interest Payable |
875,915.96 |
| Dividend Payable |
-- |
| Other payables |
9,327,971.63 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,301,353.22 |
| Other Current Liabilities |
933,052.62 |
| Sub-Total of Current Liabilities |
410,059,853.13 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
12,636,446.93 |
| Deferred Income Tax Liabilities |
792,709.20 |
| Other Non-Current Liabilities |
12,600,000.00 |
| Sub-Total of Non-Current Liabilities |
33,806,558.94 |
| Total Liabilities |
443,866,412.07 |
| Paid-In Capital(Or Share Stock) |
147,757,438.00 |
| Capital Surplus |
890,381,801.48 |
| Surplus Reserve |
67,350,275.86 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
466,257,180.81 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,563,941,423.71 |
| Owner's Equity（Stockholder's Equity） |
1,563,941,423.71 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,007,807,835.78 |
